Literature DB >> 18506359

A dipeptide YY derived from royal jelly proteins inhibits renin activity.

Afroza Sultana1, A H M Nurun Nabi, Uddin M Nasir, Hiroe Maruyama, Kazu-Michi Suzuki, Satoshi Mishima, Fumiaki Suzuki.   

Abstract

Renin is the rate limiting enzyme in the renin-angiotensin (RA) system that regulates blood pressure and electrolyte balance. In this study, we investigated the renin inhibitory effect of a royal jelly (RJ)-derived peptide. A dipeptide YY was isolated from the digested fraction of RJ proteins by proteases and was found to inhibit human renin activity. The inhibition constant (Ki) of YY was estimated to be 10 microM when the Km was 0.16 microM using sheep angiotensinogen as the substrate. The peptide was observed to lower blood pressure in spontaneously hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506359

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  4 in total

1.  Lifespan-extending effects of royal jelly and its related substances on the nematode Caenorhabditis elegans.

Authors:  Yoko Honda; Yasunori Fujita; Hiroe Maruyama; Yoko Araki; Kenji Ichihara; Akira Sato; Toshio Kojima; Masashi Tanaka; Yoshinori Nozawa; Masafumi Ito; Shuji Honda
Journal:  PLoS One       Date:  2011-08-09       Impact factor: 3.240

Review 2.  Anti-Hypertensive Effects of Peptides Derived from Rice Bran Protein.

Authors:  Naohisa Shobako; Kousaku Ohinata
Journal:  Nutrients       Date:  2020-10-07       Impact factor: 5.717

3.  Royal Jelly and Aliskiren mutually annul their protective effects against gentamicin-induced nephrotoxicity in rats.

Authors:  Mohd Alaraj
Journal:  Vet World       Date:  2020-12-14

4.  A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers.

Authors:  Koichiro Fujisue; Eiichiro Yamamoto; Daisuke Sueta; Yuichiro Arima; Kyoko Hirakawa; Noriaki Tabata; Masanobu Ishii; Miwa Ito; Kenshi Yamanaga; Shinsuke Hanatani; Tadashi Hoshiyama; Hisanori Kanazawa; Seiji Takashio; Satoshi Araki; Hiroki Usuku; Taishi Nakamura; Hirofumi Soejima; Koichi Kaikita; Hiroaki Kawano; Kenichi Matsushita; Kenichi Tsujita
Journal:  J Atheroscler Thromb       Date:  2021-09-28       Impact factor: 4.394

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.